KLK4 and skin disorder: Because activation of the kallikrein/kinin system results in the release of bradykinin and its active metabolite desArg(9) bradykinin, which are involved in vasodilation and an increase in vascular permeability, it is assumed that inhibition of the kallikrein‐kinin system is a potential approach to the dermocosmetic treatment of skin disorders associated with redness.